(28152637) IV L-arginine might be a reasonable consideration in the following situations: i) Moderate to severe hyperammonemia, without immediate access to hemodialysis ii) Persistent hyperammonemia, despite hemodialysis iii) Hyperammonemia which poses an immediate threat to life (e.g., moderate to severe hyperammonemia with evidence of cerebral edema) A reasonable dose may be: (22642880) Loading bolus of 250 mg/kg (1.2 mM/kg) over 2 hours
We assessed in rats the effects of ALCAR and KET on cerebral metabolic rates for glucose (rCMRglc) and assessed clinically the effects of ALCAR in chronic pain and of KET in post-operative pain
Redness at the injection site is also common among users
A 40% relative reduction in pneumonia incidence was observed in a large retrospective cohort (HR 0.60, 95% CI 0.580.62), constituting an intriguing signal that complicates any simple adverse-risk framing
Prioritizing good sleep can improve GLP-1 response and appetite regulation, according to Ohio State Health & Discovery
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients